SUVRETTA CAPITAL MANAGEMENT, LLC - ROYALTY PHARMA PLC ownership

ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 233 filers reported holding ROYALTY PHARMA PLC in Q2 2021. The put-call ratio across all filers is 1.38 and the average weighting 1.2%.

Quarter-by-quarter ownership
SUVRETTA CAPITAL MANAGEMENT, LLC ownership history of ROYALTY PHARMA PLC
ValueSharesWeighting
Q3 2023$111,158,519
+18.7%
4,095,745
+34.4%
6.01%
+19.9%
Q2 2023$93,666,286
-14.7%
3,047,0490.0%5.01%
+8.0%
Q1 2023$109,785,175
+40.7%
3,047,049
+54.3%
4.64%
+41.5%
Q4 2022$78,037,180
+5.4%
1,974,625
+7.2%
3.28%
+6.6%
Q3 2022$74,040,000
-42.8%
1,842,718
-40.1%
3.07%
-37.5%
Q2 2022$129,420,000
+64.0%
3,078,506
+52.0%
4.92%
+104.1%
Q1 2022$78,918,000
+0.7%
2,025,610
+3.0%
2.41%
+58.8%
Q4 2021$78,396,000
+42.0%
1,967,273
+28.8%
1.52%
+63.2%
Q3 2021$55,218,000
+84.7%
1,527,900
+109.5%
0.93%
+108.1%
Q2 2021$29,897,000
-28.4%
729,377
-23.8%
0.45%
-27.6%
Q1 2021$41,747,000
-76.5%
957,053
-73.1%
0.62%
-75.7%
Q4 2020$178,024,000
+50.5%
3,556,933
+26.5%
2.54%
+19.3%
Q3 2020$118,317,000
+13.2%
2,812,381
+30.6%
2.13%
-5.1%
Q2 2020$104,528,0002,153,0002.25%
Other shareholders
ROYALTY PHARMA PLC shareholders Q2 2021
NameSharesValueWeighting ↓
SIGULER GUFF ADVISERS, LLC 6,761,970$338,436,00092.73%
Vantage Consulting Group Inc 21,477,282$1,074,938,00087.53%
Memorial Sloan Kettering Cancer Center 3,565,887$178,473,00075.56%
HARVARD MANAGEMENT CO INC 14,690,780$735,274,00039.88%
ROBERT WOOD JOHNSON FOUNDATION 3,958,498$1,981,228,00021.69%
Brown University 381,759$19,107,00013.82%
Overbrook Management Corp 778,511$38,964,0009.50%
ADAGE CAPITAL PARTNERS GP, L.L.C. 38,714,280$1,937,650,0004.22%
Lagoda Investment Management, L.P. 96,885$4,849,0002.61%
HealthCor Management, L.P. 1,339,530$67,043,0002.58%
View complete list of ROYALTY PHARMA PLC shareholders